FDAnews
www.fdanews.com/articles/81628-medtronic-seen-capitalizing-on-guidant-s-woes

MEDTRONIC SEEN CAPITALIZING ON GUIDANT'S WOES

October 14, 2005

Glenn Reicin of Morgan Stanley maintained an "overweight" rating on Medtronic after the maker of medical devices raised earnings guidance. Medtronic lifted earnings-per-share guidance for the fiscal years 2006 to 2008 by 8 cents, citing a more favorable tax rate.
Forbes